EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RSK2-mediated phosphorylation and degradation of UBE2O inhibits hepatocellular carcinoma growth and resistance to radiotherapy

Yumei Huang, Anchen Qiu, Yimei Meng, Ming Lin, Yunhong Xu, Liu Yang

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Yumei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Department of Medical Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzh…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ubiquitin-Conjugating Enzymes, Liver Neoplasms, Ribosomal Protein S6 Kinases, 90-kDa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Science and Technology Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioresistance poses the main challenge in radiation therapy (RT) for liver cancer, with the DNA Damage response (DDR) being a crucial component of this resistance. Ubiquitin-conjugating enzyme E2O (UBE2O) has been implicated in regulating tumor proliferation, cholesterol metabolism, and drug resistance. However, the role of the ubiquitin-conjugating enzyme E2O (UBE2O) in DDR of liver cancer remains to be fully explored. We discovered an elevated expression of UBE2O within liver cancer tissues, which was notably associated with unfavorable prognoses in hepatocellular carcinoma (HCC) patients. Furthermore, we found that the suppression of UBE2O can effectively reduce the growth and resistance to radiotherapy of HCC cells in vitro and in vivo. Moreover, p90 ribosomal S6 kinase2 (RSK2) was confirmed as a novel interacting kinase of UBE2O, which mediated the phosphorylation and degradation of UBE2O at the Thr838 site. RSK2 inhibition promotes tumor proliferation and resistance to radiotherapy of HCC cells in vitro and in vivo, and these effects are abrogated upon UBE2O knockdown. Collectively, our work revealed that UBE2O promotes tumor progression and resistance to radiotherapy, which was negatively regulated by RSK2 for phosphorylation and degradation, indicating that the RSK2/UBE2O axis provides a potential radiosensitization target for HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularUbiquitin-Conjugating EnzymesLiver NeoplasmsRibosomal Protein S6 Kinases, 90-kDaRadiation ToleranceHumansPhosphorylationAnimalsCell ProliferationMiceCell Line, TumorMice, NudeMaleXenograft Model Antitumor AssaysFemaleProteolysisMice, Inbred BALB CGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

HCCPhosphorylationRSK2RadioresistanceUBE2O

Substanzen

Ubiquitin-Conjugating EnzymesRibosomal Protein S6 Kinases, 90-kDaribosomal protein S6 kinase, 90kDa, polypeptide 3

Autor:innen und Institutionen

  • Cancer Center, Department of Medical Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China; Zhejiang Province Key Disciplines in Trad…
  • Cancer Center, Department of Medical Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Science and Technology Program of Zhejiang Province
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Huang, Y., Qiu, A., Meng, Y., Lin, M., Xu, Y., & Yang, L. (2025). RSK2-mediated phosphorylation and degradation of UBE2O inhibits hepatocellular carcinoma growth and resistance to radiotherapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217558

Vancouver

Huang Y, Qiu A, Meng Y, Lin M, Xu Y, Yang L. RSK2-mediated phosphorylation and degradation of UBE2O inhibits hepatocellular carcinoma growth and resistance to radiotherapy. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217558

BibTeX
@article{Huang2025,
  author = {Huang, Yumei and Qiu, Anchen and Meng, Yimei and Lin, Ming and Xu, Yunhong and Yang, Liu},
  title = {RSK2-mediated phosphorylation and degradation of UBE2O inhibits hepatocellular carcinoma growth and resistance to radiotherapy},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217558}
}
Kostenlos starten →